Delivery Order SPE2DB24D2205-SPE2DB25FEJBR
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,160.10 by the Defense Logistics Agency on August 12, 2025, for the supply of Dexcom G7 sensors. The contract represents a firm fixed price, non-set-aside award with an ultimate completion date of August 13, 2025, and will be fulfilled at the vendor's Conshohocken facility. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,047.62 by the Defense Logistics Agency on July 23, 2025, for the supply of Dexcom G7 sensors. The award, which carries an ultimate completion date of July 24, 2025, was competitively awarded with firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,250.55 for Dexcom G7 sensors, with an ultimate completion date of September 15, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,025.66 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Dexcom G7 sensors. This firm fixed-price delivery order, with completion scheduled for September 3, 2025, represents a non-competitive set-aside contract fulfilling federal medical procurement requirements. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $2,892.38 for the supply of Dexcom G7 sensors. The contract, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, carries a firm fixed price structure and represents a competitively awarded, non-set-aside transaction. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,822.66 for Dexcom G7 sensors by the Defense Logistics Agency (DLA). The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed price contract with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,493.49 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with a completion date of July 21, 2025. This firm fixed-price delivery order, issued on July 18, 2025, represents a competitively awarded transaction with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Dexcom G7 continuous glucose monitoring sensors. This firm fixed-price, non-set-aside delivery order has a ceiling value of $1,447.63 and an ultimate completion date of September 3, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Dexcom G7 sensors, with a ceiling value of $1,787.20. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $13,614.60 on September 19, 2025, for the supply of Dexcom G7 sensors under a firm fixed price contract with no set-aside designation. The contract, which is a child order under a larger Indefinite Delivery Contract vehicle, is funded by the Defense Logistics Agency's Medical Supply Chain division and has a completion date of September 22, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which is the...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEJBRDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,172.52 by the Defense Logistics Agency on September 25, 2025, for the supply of Dexcom G7 sensors. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, was competitively awarded without a set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical devices to support military and federal healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. The Dexcom G7 continuous glucose monitoring sensors delivered under this award support diabetes management capabilities within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/25/25 |